ViroPharma Sees Silver Lining In Maribavir Failure: Now There’s Cash To Go Bargain Hunting
• By Shirley Haley
A good candidate would require a limited commercial infrastructure and make use of the company’s knowledge in transplantation, CEO Milano says, trying to redirect attention from the failed antiviral.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
